In this installment of our special COVID-19 podcast series, ASH Secretary Dr. Cindy Dunbar has a conversation with Dr. John Gribben. They discuss COVID-19 infection in patients with chronic lymphocytic leukemia or indolent lymphoma, including outcomes of infection, impact of CLL status and of treatment, changes to treatment approaches in the context of the pandemic, and the issues surrounding SARS-CoV-2 vaccine in these patients. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. The article written by Drs. Martin Tallman and Jane Winter, mentioned by Dr. Dunbar in this podcast, is the July/August 2021 Presidents' Column for The Hematologist, and can be found online via https://ashpublications.org/thehematologist/article/476104/Masking-Vaccination-and-Research-Needed-to-Protect. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org. While we regularly review and update the links, resources, and FAQs posted on the ASH website to reflect the best information available at a given point in time, the COVID-19 pandemic is a rapidly evolving global health crisis. Please take note of the dates of publication for each podcast.Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/